AKT1 and hepatocellular carcinoma: MUC15 was with decreased expression in hepatocellular carcinoma (HCC), and its overexpression significantly suppressed EGF induced dimerization of EGFR and activation of PI3K-AKT pathway, which finally inhibited tumor cell migration and invasion 14.